Stem cell options for kidney disease

被引:74
作者
Hopkins, C. [1 ]
Li, J. [1 ]
Rae, F. [1 ]
Little, M. H. [1 ,2 ]
机构
[1] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia
[2] Univ Queensland, Australian Stem Cell Ctr, St Lucia, Qld 4072, Australia
关键词
kidney disease; CD133; neonephrogenesis; stem cell markers; renal stem cell; MARROW-DERIVED CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; SIDE POPULATION CELLS; ACUTE-RENAL-FAILURE; GROWTH-FACTOR; IN-VIVO; METANEPHRIC MESENCHYME; STEM/PROGENITOR CELLS; PANCREAS DEVELOPMENT; EARLY ORGANOGENESIS;
D O I
10.1002/path.2477
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Chronic kidney disease (CKD) is increasing at the rate of 6-8% per annum in the US alone. At present, dialysis and transplantation remain the only treatment options. However, there is hope that stem cells and regenerative medicine may provide additional regenerative options for kidney disease. Such new treatments might involve induction of repair using endogenous or exogenous stem cells or the reprogramming of the organ to reinitiate development. This review addresses the current state of understanding with respect to the ability of non-renal stem cell sources to influence renal repair, the existence of endogenous renal stem cells and the biology of normal renal repair in response to damage. It also examines the remaining challenges and asks the question of whether there is one solution for all forms of renal disease. Copyright (C) 2008 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
引用
收藏
页码:265 / 281
页数:17
相关论文
共 162 条
[41]   B young again [J].
Graf, Thomas ;
Busslinger, Meinrad .
IMMUNITY, 2008, 28 (05) :606-608
[42]   Six1 and Eya1 expression can reprogram adult muscle from the slow-twitch phenotype into the fast-twitch phenotype [J].
Grifone, R ;
Laclef, C ;
Spitz, F ;
Lopez, S ;
Demignon, J ;
Guidotti, JE ;
Kawakami, K ;
Xu, PX ;
Kelly, R ;
Petrof, BJ ;
Daegelen, D ;
Concordet, JP ;
Maire, P .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (14) :6253-6267
[43]   Transplantation of human fetal mesenchymal stem cells improves glomerulopathy in a collagen type Iα2-deficient mouse [J].
Guillot, P. V. ;
Cook, H. T. ;
Pusey, C. D. ;
Fisk, N. M. ;
Harten, S. ;
Moss, J. ;
Shore, I. ;
Bou-Gharios, G. .
JOURNAL OF PATHOLOGY, 2008, 214 (05) :627-636
[44]   Isolation and characterization of kidney-derived stem cells [J].
Gupta, Sandeep ;
Verfaillie, Catherine ;
Chmielewski, David ;
Kren, Stefan ;
Eidman, Keith ;
Connaire, Jeffrey ;
Heremans, Yves ;
Lund, Troy ;
Blackstad, Mark ;
Jiang, Yuehua ;
Luttun, Aernout ;
Rosenberg, Mark E. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (11) :3028-3040
[45]  
Hagiwara M, 2008, HUM GENE THER, V19, P807, DOI [10.1089/hum.2008.016, 10.1089/hgt.2008.016]
[46]   Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency [J].
Hanna, Jacob ;
Markoulaki, Styliani ;
Schorderet, Patrick ;
Carey, Bryce W. ;
Beard, Caroline ;
Wernig, Marius ;
Creyghton, Menno P. ;
Steine, Eveline J. ;
Cassady, John P. ;
Foreman, Ruth ;
Lengner, Christopher J. ;
Dausman, Jessica A. ;
Jaenisch, Rudolf .
CELL, 2008, 133 (02) :250-264
[47]   Cessation of renal morphogenesis in mice [J].
Hartman, Heather A. ;
Lai, Hsiao L. ;
Patterson, Larry T. .
DEVELOPMENTAL BIOLOGY, 2007, 310 (02) :379-387
[48]   In vivo genetic selection of renal proximal tubules [J].
Held, PK ;
Al-Dhalimy, M ;
Willenbring, H ;
Akkari, Y ;
Jiang, SG ;
Torimaru, Y ;
Olson, S ;
Fleming, WH ;
Finegold, M ;
Grompe, M .
MOLECULAR THERAPY, 2006, 13 (01) :49-58
[49]   Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury [J].
Herrera, M. B. ;
Bussolati, B. ;
Bruno, S. ;
Morando, L. ;
Mauriello-Romanazzi, G. ;
Sanavio, F. ;
Stamenkovic, I. ;
Biancone, L. ;
Camussi, G. .
KIDNEY INTERNATIONAL, 2007, 72 (04) :430-441
[50]  
Herrera MB, 2004, INT J MOL MED, V14, P1035